Phase Ib/II Study of Vebreltinib With Furmonertinib in NSCLC Patients With c-Met Amplification After EGFR-TKI Failure
Conditions
Non Small Cell Lung Cancer NSCLC
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Ordos Central Hospital, Neimeng, Neimeng, China
Peking University Cancer Hospital (Inner Mongolia Campus), Neimeng, Neimeng, China
Affiliated Hospital of Hebei University, Baoding, China
Baotou Cancer Hospital, Baotou, China
Peking University Cancer Hospital & Institute, Beijing, China
Beijing Chest Hospital, Capital Medical University, Beijing, China
Beijing Daxing District People's Hospital, Beijing, China
Peking Union Medical College Hospital, Beijing, China
Peking University People's Hospital, Beijing, China
Peking University Third Hospital, Beijing, China
The Second Hospital of Dalian Medical University, Dalian, China
Tianjin Medical University Cancer Institute & Hospital, Tianjin, China